Novartis AG

Open: 95.21 Close: 94.68 Change: -0.53

Stop reading the whole internet to decide if you want to invest in Novartis AG Stock.

The game is changing. There is a new strategy to evaluate Novartis AG fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, NVS, AG, stock, price, last, drug, …

Concept Map

Semantic Network

Stock Summary

Novartis AG researches, develops, manufactures, markets, markets healthcare products. The company operates through two segments: Innovative Medicines and Sandoz. Novarti has a license and collaboration agreement with Alnylam Pharmaceuticals.

Today's Summary

Novartis AG (NVS) stock has risen 0.4% while the S&P 500 has fallen -0.81% as of 11:40 AM on Wednesday, Oct 18. The current market share price of NVS is at $97.59.

Today's News

Novartis is reimagining medicine to improve and extend peoples lives. Novartis AG (NVS) is a Swiss pharma company, which does the manufacturing and marketing of healthcare products. The NVS stock price is currently trading at the $97.59 level after gaining 0.46% in its last intraday session. The current market share price of NVS is at $97.59 and has increased by 0.46% since its last round. Novartis AG (NVS) stock has risen 0.4% while the S&P 500 has fallen -0.81% as of 11:40 AM on Wednesday, Oct 18. Peptidream Inc: Received $7.5 million milestone fee from novartis ag based on peptide drug conjugate development contract. Novartis confirms Sandoz Spin-off for October 4, 2023 Basel, September 25, 20 23. BeiGene regains rights for cancer drug after Novartes deal termination with Novarti.

Stock Profile

"Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland."

Keywords

Are looking for the most relevant information about Novartis AG? Investor spend a lot of time searching for information to make investment decisions in Novartis AG. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: Novartis, NVS, AG, stock, price, last, drug, and the most common words in the summary are: pdf, novartis, company, market, medical, stock, job, . One of the sentences in the summary was: The current market share price of NVS is at $97.59.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pdf #novartis #company #market #medical #stock #job.